Literature DB >> 12775097

Chemoprevention of carcinoma prostate: a review.

M S Ansari1, N P Gupta, A K Hemal.   

Abstract

PURPOSE: Chemoprevention of prostate cancer is the administration of agents to prevent, inhibit, or delay progression of prostate cancer. Opportunities exist for testing various types of chemopreventive interventsion.
MATERIAL AND METHODS: The authors reviewed the relevant articles published in the last twenty years and studied the biology of the prostate cancer. An attempt is made to identify intermediate markers and surrogate endpoint markers. The various interventions and initial clinical trial results are described. End points for evaluation are mainly based on changes in PSA, changes of histological precursors, or time of onset of clinical disease.
RESULTS: Nutritional factors such as reduced fat intake, vitamin A, vitamin E, vitamin C, vitamin D, Lycopene and selenium may have a protective effect against prostate cancer.
CONCLUSION: Numerous studies implicate dietary and nutritional factors in the onset and progression of prostate cancer. Hence, it is possible that bioactive compounds (anti-oxidants) like vits. A, C, D, E, minerals like selenium and carotenoids like lycopene can be a part of chemopreventive strategies for prostate cancer. Ongoing studies on nutrition and prostate cancer may bring the required evidence to support what is still only a hypothesis at present. However, absolute recommendation will have to await the results of long term prospective clinical trials.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12775097     DOI: 10.1023/a:1023297725004

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  41 in total

Review 1.  Diagnosis of prostatic intraepithelial neoplasia: Prostate Working Group/consensus report.

Authors:  D G Bostwick; R Montironi; I A Sesterhenn
Journal:  Scand J Urol Nephrol Suppl       Date:  2000

2.  Effect of vitamin C on prostate cancer cells in vitro: effect on cell number, viability, and DNA synthesis.

Authors:  C Maramag; M Menon; K C Balaji; P G Reddy; S Laxmanan
Journal:  Prostate       Date:  1997-08-01       Impact factor: 4.104

3.  Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression.

Authors:  M M Webber; S T Quader; H K Kleinman; D Bello-DeOcampo; P D Storto; G Bice; W DeMendonca-Calaca; D E Williams
Journal:  Prostate       Date:  2001-04       Impact factor: 4.104

4.  1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells.

Authors:  G G Schwartz; M H Wang; M Zang; R K Singh; G P Siegal
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1997-09       Impact factor: 4.254

5.  Chemoprevention of rat prostate carcinogenesis by early and delayed administration of dehydroepiandrosterone.

Authors:  K V Rao; W D Johnson; M C Bosland; R A Lubet; V E Steele; G J Kelloff; D L McCormick
Journal:  Cancer Res       Date:  1999-07-01       Impact factor: 12.701

6.  A nonsteroidal anti-inflammatory drug, flufenamic acid, inhibits the expression of the androgen receptor in LNCaP cells.

Authors:  W Zhu; A Smith; C Y Young
Journal:  Endocrinology       Date:  1999-11       Impact factor: 4.736

7.  Preprostatectomy: A clinical model to study stromal-epithelial interactions.

Authors:  W Lopaczynski; A M Hruszkewycz; R Lieberman
Journal:  Urology       Date:  2001-04       Impact factor: 2.649

8.  Early effects of retinoic acid on proliferation, differentiation and apoptosis in non-small cell lung cancer cell lines.

Authors:  A Lokshin; H Zhang; J Mayotte; M Lokshin; M L Levitt
Journal:  Anticancer Res       Date:  1999 Nov-Dec       Impact factor: 2.480

9.  Correlation of increased apoptosis and proliferation with development of prostatic intraepithelial neoplasia (PIN) in ventral prostate of the Noble rat.

Authors:  W Xie; Y C Wong; S W Tsao
Journal:  Prostate       Date:  2000-06-15       Impact factor: 4.104

10.  Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-year follow-up of the prospective Basel study.

Authors:  M Eichholzer; H B Stähelin; K F Gey; E Lüdin; F Bernasconi
Journal:  Int J Cancer       Date:  1996-04-10       Impact factor: 7.396

View more
  2 in total

Review 1.  Vitamin K and its analogs: Potential avenues for prostate cancer management.

Authors:  Subramanyam Dasari; Syed M Ali; Guoxing Zheng; Aoshuang Chen; Venkata Satish Dontaraju; Maarten C Bosland; Andre Kajdacsy-Balla; Gnanasekar Munirathinam
Journal:  Oncotarget       Date:  2017-05-19

Review 2.  Dietary Factors and Prostate Cancer Development, Progression, and Reduction.

Authors:  Michał Oczkowski; Katarzyna Dziendzikowska; Anna Pasternak-Winiarska; Dariusz Włodarek; Joanna Gromadzka-Ostrowska
Journal:  Nutrients       Date:  2021-02-03       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.